Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
FOLD:NASDAQ
Amicus Therapeutics, Inc.
$14.49
+0.21%
(+0.030) 1D
$14.49
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FOLD...
Open
$14.49
High
$14.50
Low
$14.49
Mkt. cap
4.55B
Avg. vol.
3.30M
Volume
5.29M
52-wk high
$14.50
52-wk low
$5.51
EPS
-$0.09
Beta
0.48
Shares outstanding
314.00M
No. of employees
511
News stories
From sources across the web
Profile
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
About Amicus Therapeutics, Inc.
CEOBradley L Campbell
Employees511
FoundedFeb 4, 2002
Headquarters-
SectorBiotechnology
Websiteamicusrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
125.25M
154.69M
169.06M
185.21M
Cost of goods sold
11.70M
15.22M
19.47M
26.55M
Cost of revenue
11.70M
15.22M
19.47M
26.55M
Research and development expenses
27.84M
60.85M
23.42M
23.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.83M
84.54M
90.04M
117.08M
Operating expense
121.50M
147.24M
115.32M
142.72M
Total operating expenses
133.20M
162.46M
134.79M
169.27M
Operating income
-7.95M
-7.77M
34.27M
15.95M
Other non operating income
550.00K
1.02M
10.89M
-2.21M
EBT including unusual items
-18.04M
-19.18M
34.27M
3.14M
EBT excluding unusual items
-18.04M
-17.48M
34.27M
3.14M
Income tax expense
3.64M
5.24M
16.97M
1.45M
Effective tax rate
-20.18%
-27.31%
49.51%
46.23%
Other operating expenses
-
-
-
-
Net income
-21.69M
-24.42M
17.31M
1.69M
Net profit margin
-17.31%
-15.79%
10.24%
0.91%
Earnings per share
0.03
0.01
0.17
0.10
Interest and investment income
812.00K
843.00K
829.00K
833.00K
Interest expense
-11.46M
-11.56M
-11.71M
-11.43M
Net interest expenses
-10.64M
-10.72M
-10.88M
-10.60M
Depreciation and amortization charges
1.84M
1.85M
1.87M
1.90M
EBITDA
-6.12M
-5.92M
36.14M
17.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer